chr20-5115453-G-C
Position:
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2
The NM_182649.2(PCNA):āc.702C>Gā(p.Pro234Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00277 in 1,613,998 control chromosomes in the GnomAD database, including 30 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Genomes: š 0.0016 ( 2 hom., cov: 33)
Exomes š: 0.0029 ( 28 hom. )
Consequence
PCNA
NM_182649.2 synonymous
NM_182649.2 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.00100
Genes affected
PCNA (HGNC:8729): (proliferating cell nuclear antigen) The protein encoded by this gene is found in the nucleus and is a cofactor of DNA polymerase delta. The encoded protein acts as a homotrimer and helps increase the processivity of leading strand synthesis during DNA replication. In response to DNA damage, this protein is ubiquitinated and is involved in the RAD6-dependent DNA repair pathway. Two transcript variants encoding the same protein have been found for this gene. Pseudogenes of this gene have been described on chromosome 4 and on the X chromosome. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -16 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.67).
BP6
Variant 20-5115453-G-C is Benign according to our data. Variant chr20-5115453-G-C is described in ClinVar as [Benign]. Clinvar id is 786675.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr20-5115453-G-C is described in Lovd as [Benign].
BS2
High Homozygotes in GnomAd4 at 2 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PCNA | NM_182649.2 | c.702C>G | p.Pro234Pro | synonymous_variant | 5/6 | ENST00000379143.10 | NP_872590.1 | |
PCNA | NM_002592.2 | c.702C>G | p.Pro234Pro | synonymous_variant | 6/7 | NP_002583.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PCNA | ENST00000379143.10 | c.702C>G | p.Pro234Pro | synonymous_variant | 5/6 | 1 | NM_182649.2 | ENSP00000368438.5 | ||
PCNA | ENST00000379160.3 | c.702C>G | p.Pro234Pro | synonymous_variant | 6/7 | 5 | ENSP00000368458.3 |
Frequencies
GnomAD3 genomes AF: 0.00162 AC: 247AN: 152166Hom.: 3 Cov.: 33
GnomAD3 genomes
AF:
AC:
247
AN:
152166
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00275 AC: 691AN: 251352Hom.: 7 AF XY: 0.00340 AC XY: 462AN XY: 135844
GnomAD3 exomes
AF:
AC:
691
AN:
251352
Hom.:
AF XY:
AC XY:
462
AN XY:
135844
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00289 AC: 4231AN: 1461714Hom.: 28 Cov.: 31 AF XY: 0.00314 AC XY: 2284AN XY: 727166
GnomAD4 exome
AF:
AC:
4231
AN:
1461714
Hom.:
Cov.:
31
AF XY:
AC XY:
2284
AN XY:
727166
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00160 AC: 244AN: 152284Hom.: 2 Cov.: 33 AF XY: 0.00160 AC XY: 119AN XY: 74450
GnomAD4 genome
AF:
AC:
244
AN:
152284
Hom.:
Cov.:
33
AF XY:
AC XY:
119
AN XY:
74450
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
19
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 31, 2019 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
PCNA-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Sep 10, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at